Equities

Curaleaf Holdings Inc

CURA:TOR

Curaleaf Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)3.10
  • Today's Change-0.05 / -1.59%
  • Shares traded689.62k
  • 1 Year change-30.49%
  • Beta1.3900
Data delayed at least 15 minutes, as of Nov 14 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income(239)(265)(215)
Depreciation/depletion196156121
Non-Cash items116105102
Cash taxes paid, supplemental10015692
Cash interest paid, supplemental987933
Changes in working capital3266(56)
Total cash from operations7546(58)
INVESTING
Capital expenditures(70)(135)(172)
Other investing and cash flow items, total(8.38)(85)7.98
Total cash from investing(79)(220)(164)
FINANCING
Financing cash flow items(16)(14)36
Total cash dividends paid------
Issuance (retirement) of stock, net0.05(0.81)244
Issuance (retirement) of debt, net(51)56169
Total cash from financing(67)42449
NET CHANGE IN CASH
Foreign exchange effects(0.92)(4.47)(1.08)
Net change in cash(71)(136)226
Net cash-begin balance/reserved for future use16329974
Net cash-end balance/reserved for future use92163299
SUPPLEMENTAL INCOME
Depreciation, supplemental196156121
Cash interest paid, supplemental987933
Cash taxes paid, supplemental10015692
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.